Brought to you by:
BEST-CLI: Analysis finds correlation between WIfI stage four CLTI and reports of poorer mental health
The BEST-CLI dataset has revealed a correlation between wounds, ischemia and foot infection (WIfI) stage and poorer quality of life due to mental, rather than physical, health for patients with chronic limb threatening ischemia (CLTI). Analyzing complete WIfI data from…
Bentley launches rebranded crossing catheter
Germany-based endovascular device company Bentley announced the launch of the BeBack crossing catheter—formerly known as the GoBack—designed for the treatment of heavily calcified lesions above and below the knee. Bentley acquired the catheter in September 2022 from Upstream Peripheral Technologies,…
Human-tissue engineered blood vessels remain durable at six years in PAD patients, latest study results show
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72 months of 60% measured by Kaplan Meier. There was no evidence of graft rejection or infection,…
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter Gloviczki, MD, and Senior Editor Peter Lawrence, MD, ended their six-year run as editors of all…
SVS Foundation changes name of program aimed at providing care for underserved patients
The Society for Vascular Surgery (SVS) Foundation program formerly known as VISTA has a new name. VISTA—an acronym for Vascular Volunteers In Service To All—is now simply Vascular Care for the Underserved™. Its mission, however, remains the same: “to provide…
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled trial (RCT) raised some of the early fault lines developing between different interpretations of the study’s key…
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced data presented at the 2022 VEITHsymposium (Nov. 15–19) in New York City that demonstrated that Flex…
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers, MD, from the University of Leicester, presenting, “CLTI CQUIN [Commissioning for Quality and Innovation] has raised…
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data show
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. This is according to Daniel Bertges, MD, a vascular surgeon…
Efemoral Medical closes financing round to fund ongoing study of its vascular scaffold system
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced cohort of new investors, the proceeds will further Efemoral’s device development and expand enrollment in its…